neolexon develops digital solutions for speech and language therapy. Our apps are registered as medical devices, our aphasia app is approved as a Digital Health Application (DiGA) and is thus reimbursed by all statutory health insurances in Germany.
Our aphasia app enables people with speech loss after brain damage to train independently and indefinitely at home in addition to logopedic treatment. The training material and the difficulty of the exercises are selected individually for the patient by the speech therapist. Due to a high degree of user-friendliness, patients with motor, visual and cognitive impairments can also practice independently.
For children with articulation disorders, our articulation app with five different game modules offers varied and individual training as a supplement to therapy with the speech therapist. A reward system and the possibility to personalize the main character with new hairstyles, clothes and disguises increase the motivation to practice regularly at home.
Company Details
- Employees
- 14
- Founded
- -
- Address
- Sendlinger Straße 2, München,bayern 80331,germany
- Industry
- Information Technology & Services
- Website
- https://neolexon.de/
- Keywords
- München.
- HQ
- München, Bayern
Neolexon Questions
Neolexon's website is https://neolexon.de/
Neolexon's LinkedIn profile is https://de.linkedin.com/company/neolexon
Neolexon has
14 employees.
View email and phone details for 14
employees at Neolexon.
Neolexon's industry is
Information Technology & Services
Neolexon's top competitors are
Temedica,
Kaia Health,
Selfapy,
Hellobetter,
Imrox,
Compugroup Medical Se & Co. Kgaa,
Cara Care,
Spitzenverband Digitale Gesundheitsversorgung,
Subrosa Health & Capital Group,
Doctolib.
Neolexon's categories are Information Technology & Services
Neolexon's founding year is 2017
